Stock listing
Frankfurt:IDD Innate Pharma SA Aktie
German listing (Frankfurt) of Innate Pharma SA · home listing Euronext:IPH
Follow Innate Pharma SA into a list and get an email when it puts out news.
Share price · FWB:IDD
€1.28 EUR -0.01 (-0.9%)
Close on Oct 30, 2026
- Day range
- €1.28 – €1.28 EUROct 30, 2026
- Market cap
- €143.0M EURAt the close on Oct 30, 2026 · price × 111.7M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:IPH · Home | €1.256 EUR | -0.03 (-2.3%) | 171,440 | €1.274 | €1.28 | €1.244 | €1.286 | Close on Oct 30, 2026 |
| NASDAQ:IPHA | $1.48 USD | -0.02 (-1.3%) | 16,826 | $1.46 | $1.50 | $1.45 | $1.50 | Close on Oct 27, 2026 |
| OTC:IPHYF | $1.509 USD | 0.00 (0.0%) | — | $1.509 | $1.509 | $1.509 | $1.509 | Close on Oct 27, 2026 |
| Frankfurt:IDDA | €1.28 EUR | +0.01 (+0.8%) | — | €1.14 | €1.28 | €1.13 | €1.27 | Close on Oct 30, 2026 |
| Frankfurt:IDD | €1.28 EUR | -0.012 (-0.9%) | — | €1.28 | €1.28 | €1.28 | €1.292 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:IDD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 27, 2026
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
Latest earnings call · May 13, 2026
Innate Pharma (Euronext:IPH) Q1 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Q2 2026 Earnings Presentation
Earnings · 34 slides
Calls
Replays
Innate Pharma (Euronext:IPH) Q1 2026 Earnings Call
Wed, May 13, 2026 · 7:30 AM ET
Watch TranscriptInnate Pharma (Euronext:IPH) Q4 2025 Earnings Call
Thu, Mar 26, 2026 · 9:00 AM ET
Watch TranscriptInnate Pharma (Euronext:IPH) Q3 2025 Earnings Call
Thu, Nov 13, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Financings
Private placement of new ordinary shares
Aug 14, 2026 · US$34.72M
Update: about €30M · €1.7 a share · Stifel +1
Dealers: Stifel (lead), BTIG (co-lead)
Buyers: Bpifrance Participations S.A. (committed to place a €3 million order in the book)
Use of proceeds: Clinical development of IPH4502, advancing preclinical ADC portfolio candidates, working capital and general corporate purposes
Decks
Q2 2026 Earnings Presentation
Earnings · 34 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 25 slides · May 13, 2026
Investor Presentation (May 2026)
Investor deck · 39 slides · May 2026
Investor Presentation (March 2026)
Investor deck · 40 slides · Mar 26, 2026
Innate Pharma SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 37 in the last 12 months · 57 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 15 calls with a replay · 15 with a transcript · latest May 13, 2026
- Decks
- 76 decks · latest August 2026
Where Innate Pharma SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:IPH · Home listing | Euronext | France | EUR |
| NASDAQ:IPHA | NASDAQ | United States | USD |
| gettex:IDD | gettex | Germany | EUR |
| EUROTLX:4IPH | EUROTLX | Italy | EUR |
| OTC:IPHYF | OTC | United States | USD |
| LSIN:0EVI | LSIN | United Kingdom | EUR |
| LS Exchange:A0LCUJ | LS Exchange | Germany | EUR |
| Aquis:IPHP | Aquis | United Kingdom | EUR |
| Lang & Schwarz:A0LCUJ | Lang & Schwarz | Germany | EUR |
| Aquis:IPHP | Aquis | United Kingdom | EUR |
| Stuttgart:IDD | Stuttgart | Germany | EUR |
| Xetra:IDD | Xetra | Germany | EUR |
| Tradegate:IDD | Tradegate | Germany | EUR |
| Frankfurt:IDDA | Frankfurt | Germany | EUR |
| BOATS:IPHA | BOATS | United States | USD |
| gettex:IDDA | gettex | Germany | EUR |
| Frankfurt:IDD · This page | Frankfurt | Germany | EUR |
| Dusseldorf:IDD | Dusseldorf | Germany | EUR |
| Hamburg:IDD | Hamburg | Germany | EUR |
| Lang & Schwarz:A2PSSH | Lang & Schwarz | Germany | EUR |
| Munich:IDD | Munich | Germany | EUR |
| Munich:IDDA | Munich | Germany | EUR |
| LS Exchange:A2PSSH | LS Exchange | Germany | EUR |
| Stuttgart:IDDA | Stuttgart | Germany | EUR |
| Turquoise:IPHP | Turquoise | United Kingdom | EUR |
| Hanover:IDD | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Innate Pharma SA.